Billing and Claims

Gain insights into CMS' proposals for the 340B drug discount program.

Understand how proposals for professional reimbursement could have far-reaching affects on clinics and hospitals.

Learn how revenue integrity leaders are applying and preparing for advanced technology.

Apply these lessons to reduce denials and support efficient processes.

One of the most common errors seen in skin substitute claims is the inappropriate application of drug waste modifiers, which are as follows:

Review recent billing and coding updates concerning critical care, telehealth, and other evaluation and management (E/M) services.

Q: How can we improve correct use of drug waste modifiers on skin substitute claims?

The Office of Inspector General (OIG) released a report on billing patterns for remote patient monitoring (RPM) services, highlighting the expanding use of these services and a need for additional oversight.